CXCL1 and obesity due to melanocortin 4 receptor deficiency: We also use the mouse model to demonstrate that blockade of either CXCL1 or its receptors inhibits obesity-dependent ASC tumour trafficking and abrogates the obesity-associated promotion of tumour vascularization and growth.